Cite
APA Citation
Kijak, G. H., Ahani, B., Arbetter, D., Brady, T., Chuecos, F., Gopalakrishnan, V., Roe, T. L., Schuko, N., Richard Hobbs, F. D., Padilla, F., Kelly, E. J., Montgomery, H., & Streicher, K. (n.d.). 1160. Treatment-Emergent Viral Variants in the Phase 3 TACKLE Trial Investigating Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for the Treatment of Mild to Moderate COVID-19 in Adults. Open forum infectious diseases, 9, . http://access.bl.uk/ark:/81055/vdc_100174901109.0x00000f